Electromed (ELMD) Competitors

AxoGen (NASDAQ:AXGN) and Electromed (NYSE:ELMD) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, media sentiment, risk, institutional ownership, community ranking, profitability, analyst recommendations, valuation and dividends.

Which has more risk & volatility, AXGN or ELMD?

AxoGen has a beta of 1, indicating that its share price has a similar volatility profile to the S&P 500.Comparatively, Electromed has a beta of 0.59, indicating that its share price is 41% less volatile than the S&P 500.

Does the MarketBeat Community believe in AXGN or ELMD?

AxoGen received 435 more outperform votes than Electromed when rated by MarketBeat users. However, 91.67% of users gave Electromed an outperform vote while only 72.89% of users gave AxoGen an outperform vote.

Company	Underperform	Outperform
AxoGen	Outperform Votes 457 72.89%	Underperform Votes 170 27.11%
Electromed	Outperform Votes 22 91.67%	Underperform Votes 2 8.33%

Do insiders and institutionals hold more shares of AXGN or ELMD?

80.3% of AxoGen shares are owned by institutional investors. Comparatively, 40.8% of Electromed shares are owned by institutional investors. 7.0% of AxoGen shares are owned by insiders. Comparatively, 14.0% of Electromed shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Which has stronger earnings & valuation, AXGN or ELMD?

Electromed has lower revenue, but higher earnings than AxoGen. AxoGen is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AxoGen	$187.34M	3.70	-$21.72M	-$0.22	-71.14
Electromed	$59.63M	3.29	$5.15M	$0.75	30.57

Is AXGN or ELMD more profitable?

Electromed has a net margin of 11.34% compared to AxoGen's net margin of -7.91%. Electromed's return on equity of 15.71% beat AxoGen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AxoGen	-7.91%	-14.91%	-7.49%
Electromed	11.34%	15.71%	13.37%

Do analysts rate AXGN or ELMD?

AxoGen currently has a consensus target price of $22.60, suggesting a potential upside of 44.41%. Electromed has a consensus target price of $38.00, suggesting a potential upside of 65.72%. Given Electromed's stronger consensus rating and higher probable upside, analysts plainly believe Electromed is more favorable than AxoGen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AxoGen	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	3.00
Electromed	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	4.00

Does the media favor AXGN or ELMD?

In the previous week, AxoGen had 5 more articles in the media than Electromed. MarketBeat recorded 8 mentions for AxoGen and 3 mentions for Electromed. Electromed's average media sentiment score of 1.63 beat AxoGen's score of 1.29 indicating that Electromed is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AxoGen	6 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Electromed	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

Electromed beats AxoGen on 12 of the 19 factors compared between the two stocks.